4,806
Views
16
CrossRef citations to date
0
Altmetric
Research Articles

Microbubble drug conjugate and focused ultrasound blood brain barrier delivery of AAV-2 SIRT-3

, , , , , & show all
Pages 1176-1183 | Received 31 Dec 2021, Accepted 25 Jan 2022, Published online: 08 Apr 2022

References

  • Burgess A, Shah K, Hough O, et al. (2015). Focused ultrasound-mediated drug delivery through the blood-brain barrier. Expert Rev Neurother 15:477–91.
  • De Carlo F, Thomas L, Brooke B, et al. (2019). Microbubble-mediated delivery of human adenoviruses does not elicit innate and adaptive immunity response in an immunocompetent mouse model of prostate cancer. J Transl Med 17:19.
  • GDB 2016 Parkinson’s Disease Collaborators (2018). Global, Regional, and National Burden of Parkinson’s Disease, 1990-2016: A systemic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 7:939–53.
  • Gleave JA, Arathoon LR, Trinh D, et al. (2018). Corrigendum to Sirtuin 3 rescues neurons through the stabilisation of mitochondrial biogenetics in the virally-expressing mutant α-synuclein rat model of parkinsonism. Neurobiol Dis 106:133–46.
  • Gleave J, Nash J, et al. (2017). Sirtuin 3 rescues neurons through the stabilisation of mitochondrial biogenetics in the virally-expressing mutant α-synuclein rat model of Parkinsonism. Neurobiol Dis.
  • Hynynen K, et al. (2019). MRI-guided focused ultrasound for targeted delivery of rAAV to the brain. Methods Mol Biol 1950:177–97.
  • Kruzik A, Fetahagic D, Hartlieb B, et al. (2019). Prevalence of anti-adeno-associated virus immune responses in international cohorts of healthy donors. Mol Ther Methods Clin Dev 14:126–33.
  • Lin K, Zhong X, Li L, et al. (2020). AAV9-Retro mediates efficient transduction with axon terminal absorption and blood-brain barrier transportation. Mol Brain 13:138.
  • Mainprize T, Lipsman N, Huang Y, et al. (2019). Blood-brain barrier opening in primary brain tumors with non-invasive MR-guided focused ultrasound: a clinical safety and feasibility study. Sci Rep 9:321.
  • McDannold N, Arvanitis CD, Vykhodtseva N, et al. (2012). Temporary disruption of the blood-brain barrier by use of ultrasound and microbubbles: safety and efficacy evaluation in rhesus macaques. Cancer Res 72:3652–63.
  • Qian G, et al. (2019). Drug-loaded microbubbles combined with ultrasound for thrombolysis and malignant tumor therapy. Biomed Res Int. 6792465.
  • Stavarache MA, Petersen N, Jurgens EM, et al. (2018). Safe and stable noninvasive focal gene delivery to the mammalian brain following focused ultrasound. J Neurosurg 130:989–98.
  • Wang F, Shi Y, Lu L, et al. (2012). Targeted delivery of GDNF through the blood-brain barrier by MRI-guided focused ultrasound. PLoS One 7:e52925,
  • Yanagisawa K, Moriyasu F, Miyahara T, et al. (2007). Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. Ultrasound Med Biol 33:318–25.
  • Zhang J, Wang S, Deng Z, et al. (2018). Ultrasound-triggered drug delivery for breast tumor therapy through iRGD-targeted paclitaxel-loaded liposome-microbubble complexes. J Biomed Nanotechnol 14:1384–95.